相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up The BRECARD Study
Celestino Sardu et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Atherosclerotic Plaque Fissuration and Clinical Outcomes in Pre-Diabetics vs. Normoglycemics Patients Affected by Asymptomatic Significant Carotid Artery Stenosis at 2 Years of Follow-Up: Role of microRNAs Modulation: The ATIMIR Study
Celestino Sardu et al.
BIOMEDICINES (2021)
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients
Nunzia D'Onofrio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
Ferdinando Carlo Sasso et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study
Celestino Sardu et al.
DIABETES CARE (2019)
Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients
Nunzia D'Onofrio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
Celestino Sardu et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial
Jordi Salas-Salvado et al.
DIABETES CARE (2019)
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
Hiroto Oshima et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
Ven G. Lim et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Metformin: Mechanisms in Human Obesity and Weight Loss
Armen Yerevanian et al.
CURRENT OBESITY REPORTS (2019)
SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management
Michael J. B. van Baar et al.
DIABETES CARE (2018)
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
W. Timothy Garvey et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients
Celestino Sardu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Pericoronary Adipose Tissue: A Novel Therapeutic Target in Obesity-Related Coronary Atherosclerosis
Tomasz Mazurek et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2015)